Ezetimibe added to a statin results in greater LDL reduction

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2002年 / 37卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [1] Ezetimibe added to statin results in greater achievement of LDL goals
    不详
    FORMULARY, 2004, 39 (05) : 242 - 242
  • [2] CHANGES IN PRESCRIPTION PATTERNS FOR EZETIMIBE/SIMVASTATIN, EZETIMIBE plus STATIN AND STATIN THERAPIES AND EXPECTED EFFECTS ON LDL-C REDUCTION
    Toth, P.
    Ballantyne, C.
    Davidson, M.
    Ramey, D.
    Neff, D.
    Tershakovec, A.
    Hu, H.
    Tomassini, J.
    Tunceli, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 128 - 129
  • [3] C-REACTIVE PROTEIN (CRP) AND LDL-CHOLESTEROL RESPONSE TO EZETIMIBE MONOTHERAPY AND TO EZETIMIBE ADDED-ON TO BASELINE STATIN THERAPY
    Pearson, T.
    Ballantyne, C.
    Veltri, E.
    Shah, A.
    Bird, S.
    Lin, J.
    Rosenberg, E.
    Tershakovec, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 187 - 187
  • [4] Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy
    Gonzalez, Carlos A.
    Rubio-Guerra, Alberto F.
    Pavia, Abel
    Redding, Francisco J.
    Cervantes, Jose L.
    Zacarias, Jose L.
    Yza, Ruben
    Carranza, Jaime
    Fernandez, Pedro
    Morales, Enrique
    Robles, Francisco J.
    Leyva, Jose L.
    Rodriguez, Leticia
    CLINICAL DRUG INVESTIGATION, 2007, 27 (05) : 333 - 337
  • [5] Effectiveness and Safety of Ezetimibe Added to Statin Therapy in Patients with Primary Dyslipidaemia not Achieving the LDL- C Treatment Goal on Statin Monotherapy
    Carlos A. González
    Alberto F. Rubio-Guerra
    Abel Pavía
    Francisco J. Redding
    José L. Cervantes
    José L. Zacarías
    Rubén Yza
    Jaime Carranza
    Pedro Fernández
    Enrique Morales
    Francisco J. Robles
    José L. Leyva
    Leticia Rodríguez
    Clinical Drug Investigation, 2007, 27 : 333 - 337
  • [6] Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patients
    Thongtang, Nuntakorn
    Lin, Jianxin
    Schaefer, Ernst J.
    Lowe, Robert S.
    Tomassini, Joanne E.
    Shah, Arvind K.
    Tershakovec, Andrew M.
    ATHEROSCLEROSIS, 2012, 225 (02) : 388 - 396
  • [7] Ezetimibe added to statin therapy reduces LDL-C and improves goal attainment in patients with diabetes and metabolic syndrome
    Denke, M
    McBride, P
    Pearson, T
    Battisti, WP
    Brady, WE
    Palmisano, J
    DIABETES, 2004, 53 : A122 - A122
  • [8] Ezetimibe added to ongoing statin therapy for treatment of primary hypercholesterolemia
    Bays, H
    Weiss, S
    Gagne, C
    Mata, P
    Gumbiner, B
    Melino, M
    Quinto, K
    Cho, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 245A - 245A
  • [9] Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
    Cannon, Christopher P.
    Blazing, Michael A.
    Giugliano, Robert P.
    McCagg, Amy
    White, Jennifer A.
    Theroux, Pierre
    Darius, Harald
    Lewis, Basil S.
    Ophuis, Ton Oude
    Jukema, J. Wouter
    De Ferrari, Gaetano M.
    Ruzyllo, Witold
    De Lucca, Paul
    Im, KyungAh
    Bohula, Erin A.
    Reist, Craig
    Wiviott, Stephen D.
    Tershakovec, Andrew M.
    Musliner, Thomas A.
    Braunwald, Eugene
    Califf, Robert M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25): : 2387 - 2397
  • [10] Ezetimibe added to statin therapy after acute coronary syndromes
    Abel Tatjana
    ORVOSI HETILAP, 2015, 156 (45) : 1840 - 1840
12345